INTERNATIONAL PATENT: PAM THERAGNOSTICS GMBH FILES APPLICATION FOR "A METHOD FOR THE PREDICTION OF A RISK OR SEVERITY OF SIDE EFFECTS IN A CANCER PATIENT THAT IS TO BE TREATED OR HAS BEEN TREATED WITH IMMUNE EFFECTOR CELL THERAPY (IECT)"

GENEVA, March 9 -- PAM THERAGNOSTICS GMBH (Neuendorfstr. 15 B16761 Hennigsdorf) filed a patent application (PCT/EP2025/074252) for "A METHOD FOR THE PREDICTION OF A RISK OR SEVERITY OF SIDE EFFECTS IN A CANCER PATIENT THAT IS TO BE TREATED OR HAS BEEN TREATED WITH IMMUNE EFFECTOR CELL THERAPY (IECT)" on Aug 26, 2025. With publication no. WO/2026/046982, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KAUFMANN, Paul (c/o PAM Theragnostics GmbHNeuendorfstr. 15 B16761 Hennigsdorf), ILINA, Yulia (c/o PAM Theragnostics GmbHNeu...